These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 1803314)
1. Topical administration of leukotriene antagonists in immunogenic keratitis. van Delft JL; van Haeringen NJ; Barthen ER; van Best JA; Blackham A Ophthalmic Res; 1991; 23(6):330-4. PubMed ID: 1803314 [TBL] [Abstract][Full Text] [Related]
2. Modulation of immunogenic keratitis in rabbits by topical administration of inhibitors of lipoxygenase and cyclooxygenase. Verbey NL; van Haeringen NJ; de Jong PT Curr Eye Res; 1988 Apr; 7(4):361-8. PubMed ID: 2453319 [TBL] [Abstract][Full Text] [Related]
3. Modulation of immunogenic keratitis in rabbits by topical administration of poly-unsaturated fatty acids. Verbey NL; van Haeringen NJ; de Jong PT Curr Eye Res; 1988 Jun; 7(6):549-56. PubMed ID: 2841074 [TBL] [Abstract][Full Text] [Related]
4. Antagonists and inhibitors of lipid mediators in experimental inflammation of the cornea. van Haeringen NJ; Verbey NL; van Delft JL J Ocul Pharmacol; 1993; 9(4):365-72. PubMed ID: 8106842 [TBL] [Abstract][Full Text] [Related]
5. Solubilization and dissolution properties of a leukotriene-D4 antagonist in micellar solutions. Kararli TT; Gupta VW J Pharm Sci; 1992 May; 81(5):483-5. PubMed ID: 1403686 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid. Tomioka K; Yamada T; Mase T; Hara H; Murase K Arzneimittelforschung; 1988 May; 38(5):682-5. PubMed ID: 3415708 [TBL] [Abstract][Full Text] [Related]
7. Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes. Brown FJ; Bernstein PR; Cronk LA; Dosset DL; Hebbel KC; Maduskuie TP; Shapiro HS; Vacek EP; Yee YK; Willard AK J Med Chem; 1989 Apr; 32(4):807-26. PubMed ID: 2704027 [TBL] [Abstract][Full Text] [Related]
8. Effect of indomethacin on immunogenic keratitis. van Haeringen NJ; van Delft JL; Barthen ER; de Wolff-Rouendaal D; Oosterhuis JA Curr Eye Res; 1986 Apr; 5(4):307-11. PubMed ID: 3709209 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization. Sonoda K; Sakamoto T; Yoshikawa H; Ashizuka S; Ohshima Y; Kishihara K; Nomoto K; Ishibashi T; Inomata H Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2245-51. PubMed ID: 9804132 [TBL] [Abstract][Full Text] [Related]
10. 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8- propyl-2H-1-benzopyran-2-carboxylic acid: an orally active selective leukotriene B4 receptor antagonist. Djuric SW; Collins PW; Jones PH; Shone RL; Tsai BS; Fretland DJ; Butchko GM; Villani-Price D; Keith RH; Zemaitis JM J Med Chem; 1989 Jun; 32(6):1145-7. PubMed ID: 2542550 [No Abstract] [Full Text] [Related]
11. Second-generation leukotriene B4 receptor antagonists related to SC-41930: heterocyclic replacement of the methyl ketone pharmacophore. Penning TD; Djuric SW; Miyashiro JM; Yu S; Snyder JP; Spangler D; Anglin CP; Fretland DJ; Kachur JF; Keith RH J Med Chem; 1995 Mar; 38(6):858-68. PubMed ID: 7699700 [TBL] [Abstract][Full Text] [Related]
12. [Thiophene as a structural element of physiologically active substances. 20. Thiophene analogs of the leukotriene D4 antagonist Ro 23-3544]. Binder D; Koch A; Rovenszky F; Stroissnig H Arch Pharm (Weinheim); 1992 Dec; 325(12):797-801. PubMed ID: 1489255 [TBL] [Abstract][Full Text] [Related]